These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 16451050

  • 41. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
    Ichikawa D, Ozaki S, Azuma T, Nambu H, Kawamoto H, Iwasawa Y, Takeshima H, Ohta H.
    Neuroreport; 2001 Jun 13; 12(8):1757-61. PubMed ID: 11409754
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor.
    Geldenhuys WJ, Kuzenko SR, Simmons MA.
    J Med Chem; 2010 Nov 25; 53(22):8080-8. PubMed ID: 21047106
    [Abstract] [Full Text] [Related]

  • 44. Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonist.
    Li J, Isozaki K, Okada K, Matsushima A, Nose T, Costa T, Shimohigashi Y.
    Bioorg Med Chem; 2008 Mar 01; 16(5):2635-44. PubMed ID: 18068993
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.
    Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N.
    J Med Chem; 2006 Sep 21; 49(19):5653-63. PubMed ID: 16970392
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B, Goodman AJ, Michaut M, Ye HF, Graczyk TM, Belanger S, Herbertz T, Yap GP, DeHaven RN, Dolle RE.
    J Med Chem; 2006 Dec 14; 49(25):7278-89. PubMed ID: 17149858
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L.
    J Pharmacol Exp Ther; 2009 Dec 14; 331(3):946-53. PubMed ID: 19713488
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profiling.
    Guba W, Green LG, Martin RE, Roche O, Kratochwil N, Mauser H, Bissantz C, Christ A, Stahl M.
    J Med Chem; 2007 Dec 13; 50(25):6295-8. PubMed ID: 18020391
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.